Camden National Corporation’s Merck MRK Stock Holding History

Camden National Corporation’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$8.64M	Buy	+117,476	New	+$8.67M	1.72%	19

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Camden National Corporation's MRK Position: Q1 2021 in Review

Camden National Corporation opened a new position in Merck (MRK) in Q1 2021: 117,476 shares worth $8.64M. The stake represents 1.72% of the portfolio and ranks #19 among its holdings.

2,687 funds tracked by Wall St. Rank hold MRK as of Q1 2021.

Camden National Corporation held 117,476 shares of Merck worth $8.64M as of Q1 2021.
Merck was a new Camden National Corporation position in Q1 2021.
Merck made up 1.72% of Camden National Corporation's portfolio in Q1 2021, its #19 holding.
2,687 funds tracked by Wall St. Rank held Merck as of Q1 2021.

Based on Camden National Corporation's 13F filing for Q1 2021, filed 12 May 2021.